Antibody combined with statin results in further reduction of cholesterol levels
Among patients with high cholesterol receiving moderate- or high-intensity statin therapy, the addition of the human monoclonal antibody evolocumab resulted in additional lowering of low-density lipoprotein cholesterol (LDL-C) ...
May 13, 2014
0
0